SME Times is powered by   
Search News
Just in:   • India-New Zealand are working toward early conclusion of trade agreement: Piyush Goyal  • Assembly polls: Bihar records 13.13 per cent voter turnout in first two hours  • Panel formed to finalise new wage pact for TN's Tiruppur knitwear workers  • India 2nd in consumer demand of gold globally, RBI reserves rise to 880 tonnes  • Piyush Goyal to reach New Zealand tomorrow to speed up trade talks 
Last updated: 02 Jul, 2022  

Tablet.9.Thmb.jpg 'Time to move from 'Volume' to 'Value' leadership in Pharma market'

Tablet.9.jpg
   Top Stories
» India-New Zealand are working toward early conclusion of trade agreement: Piyush Goyal
» Panel formed to finalise new wage pact for TN's Tiruppur knitwear workers
» India 2nd in consumer demand of gold globally, RBI reserves rise to 880 tonnes
» Piyush Goyal to reach New Zealand tomorrow to speed up trade talks
» PM Modi inaugurates ESTIC 2025, launches Rs one lakh crore RDI Scheme Fund
IANS | 02 Jul, 2022
Let us move from 'Volume' to 'Value' leadership to capture global pharmaceutical market, said Union Health Minister Mansukh said on Saturday.

He told the leaders of Pharma industry that it is time to accumulate knowledge from global best practices in research, manufacturing and innovation and develop own models focused on accelerating production to meet the domestic demand while increasing global footprint.

Mandaviya was discussing India's Pharma Vision 2047 and roadmap for the Indian pharmaceutical sector with Indian Pharmaceutical Alliance.

The session discussed the current position of the pharma industry in India, key initiatives taken by the Government in the last few years and collaborative steps that will help India realize this vision.

"We already have the required man power and brand power and Indian companies today are at an inflexion point to capture top global positions", said Mandaviya, adding that India has been acknowledged as pharmacy of the world based on its generic medicines production and the volume share in global market. It is time to move ahead and capture the top global positions based on the value too, he stressed.

Emphasising that the Government is committed to supporting the Pharma Companies with Industry-Friendly policies and investor promoting ecosystem, he said, "This Government believes in taking a holistic approach. Our policies are based on extensive and comprehensive stakeholder consultation which provide the basis for comprehensive, long-term and vibrant policy ecosystem".

The government will strengthen the sector through streamlining policies and effective schemes such as the PLI which support cutting edge research, he said. Apart from policy front, Mandaviya also focused on the investments in research and development, efficient manufacturing capacities along with creating ample opportunities for innovation that is the need of the hour now.
 
Print the Page
Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
₹88.70
₹87
UK Pound
₹119.90
₹116
Euro
₹104.25
₹100.65
Japanese Yen ₹59.20 ₹57.30
As on 30 Oct, 2025
  Daily Poll
Who do you think will benefit more from the India - UK FTA in the long run?
 Indian businesses & consumers.
 UK businesses & consumers.
 Both will gain equally.
 The impact will be negligible for both.
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter